Background: Patients suffering from nasal obstruction due to external nasal valve dysfunction may benefit from either corrective surgery or a conservative approach with a nasal dilator. At present, devices for widening the external nasal valve region can be applied externally or endonasally. It remains unknown to what extent the endonasal dilator Airmax® objectively improves the nasal flow and can be offered as an alternative for surgery.
Introduction
Patients with nasal obstruction may have a variety of mucosal and/or anatomical abnormalities being responsible for their impaired nasal breathing. The distinction between mucosal and anatomical abnormalities is made on the base of a proper clinical examination (1) . Among the non-mucosal etiologies of nasal obstruction, nasal septal deviation, septal perforations and/or valve dysfunction are the most frequently encountered conditions. In patients with nasal obstruction, external valve problems are often overlooked in spite of the ease of clinical examination.
Inadequate function of the outer valve with either alar collapse at the time of nasal inspiration and/or narrow nostrils may become obvious by performing the Cottle test (2) . The latter test involves the evaluation of the subjective improvement in nasal breathing by widening the external valve area via either manual distraction of the cheek in lateral direction or by lateral displacement of the lateral crurae by non-traumatic instruments. (3) , or lateral crural pull up techniques (4, 5) have been reported to improve the nasal breathing. Of note, the functional restoration of the nasal valve region may involve broadening of the alar vault region of the nose (6) . Therefore, aesthetical considerations have to be taken into account at the time of scheduling a surgical intervention, as patients need to be fully aware of the consequences of the surgery.
In those patients where surgery is not primarily indicated or desired by the patient, non-surgical options should be discussed.
Several devices for external or endonasal widening of the valve area have been designed for use by sportsmen, snorers and/ or patients with nasal breathing problems. So far, we lack good data on the objective improvement of nasal breathing by these devices. A recent study using the endonasal dilater Nasanita® (Siemens, Germany) in 10 patients with external valve problems demonstrated beneficial effects on alar collapse and active anterior rhinomanometry data (7) . Other devices like Nozovent® and Breath Right® (8) 
Materials and methods

Patients population
Patients with invalidating bilateral nasal obstruction due to external nasal valve dysfunction were selected for participation The absence of significant mucosal disease and/or rhinosinusitis was assured by nasal endoscopy. Normal active anterior rhinomanometry as well as a normal anterior acoustic rhinometry were inclusion criteria for this study.
A general medical and surgical history was taken, specifically focusing on nasal medication and previous nasal surgery. The peak nasal inspiratory flow (PNIF) was measured, at the outpatient clinic before and after application of the dilator, to evaluate the objective improvement of nasal patency and inspiratory flow. Before and after Airmax® insertion, several consecutive measurements had been made and the highest value of 3 consecutive measurements with less than 10% variability was chosen for the records, as described previously (1) .
Patients were donated one of the commercially available Airmax® kits with 2 dilators for free, and instructed to apply the device as needed during sleep, during sports and/or during daytime activities.
Evaluation of subjective satisfaction of the endonasal dilator
At 4 w after the initial consultation, patients were reevaluated at the outpatient Rhinology clinic. Patients were asked for their willingness to continue to use the device or their preference to undergo surgery to improve the nasal breathing. In those expressing the desire to stop using the nasal dilator, the major reason underlying the decision was asked and noted.
Data analyses and statistics
Statistical analysis was performed using the non-parametric, paired t-test with a value of p < 0.05 being statistically significant. Data are presented as means ± standard errors of the mean (SEM).
Results
Patient characteristics
Thirty patients with nasal obstruction primarily caused by nasal valve dysfunction and with a positive Cottle test were included in this study. The mean age of the study population was 50.4 ± 14.3 years of age, with 20 male patients (66%). Eleven of 30 patients had undergone nose surgery in the past (septal correction, turbinate reduction and/or rhinoplasty) whereas the remaining 19 had never undergone a nasal intervention. None of the patients was on current nasal anti-inflammatory treatment. 
Improvement of PNIF by the endonasal dilator
Discussion
We here demonstrate the beneficial effects of the Airmax® endonasal dilator in a real-life clinical setting. All patients with external valve dysfunction showed major benefit from the dila- This study raises several interesting issues regarding the therapeutic approach of nasal valve dysfunction. Firstly, this study offers the first step in evaluating the success of the endonasal dilator as an alternative for surgery. At present, patients with nasal valve dysfunction are being proposed to undergo either corrective valve surgery or a conservative approach using nasal dilators, without surgeons being able to give an estimated success rate of the conservative approach. Both external (Breath Right®) and as well as endonasal (Nozovent® or Airmax®) dilators have been reported to be helpful in snorers, sportsmen and patients with nasal obstruction, without data on subjective evaluation by the patient (9) (10) (11) (12) . Here, we show that 19 out of 30 selected patients with external valve problems being the reason for nasal obstruction intended to continue to use the dilator Airmax®. This argument can be used in every day clinic to explain the patients the subjective benefit of the Airmax® dilator.
Until recently, we only had limited objective data on the improvement of nasal breathing by nasal dilators (9) (10) (11) (12) . The reported improvement of nasal flow by the dilators was performed by either acustic rhinometry (9, 10) or rhinomanometry (11, 12) . Regarding the different techniques for measuring nasal flow, a European consensus group recently stated that PNIF measurements are superior to other means of evaluation of nasal flow due to the fact that PNIF data correlate with the subjective feeling of nasal obstruction and that the nasal flow is measured without distortion of the nasal valve area by a nozzle (2) . Therefore, PNIF measurements had been chosen for evaluation of nasal flow in this study.
Of note, it was interesting to observe that almost 2/3 of patients expressed the desire to continue to use the nasal dilator Airmax®. We are well aware of the fact that this high degree of patient satisfaction with this endonasal dilator does reflect a combination of factors like subjective improvement of nasal breathing, the ease of wearing the device, the lack of social inhibition by an endonasal rather than external device, and/or the fear for surgery. In the remaining 1/3, the use of the nasal dilator was discontinued on the base of several reasons that are device-related, like local irritation and inappropriate size.
Other reasons like the choice for a more definitive solution and/ or the combined functional-aesthetic improvement of the nose by the surgery can be considered as device-unrelated. Interestingly enough, none of the patients reported aesthetic or social impairment by wearing the device.
In conclusion, we here present the first data on subjective improvement of nasal flow and satisfaction in patients with nasal valve dysfunction and obstruction using the nasal dilator
Airmax®. Further studies in this field are warranted to compare the different nasal dilators and/or compare the success rate of conservative vs surgical solutions for nasal valve dysfunction.
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